Abstract
Opposing functions like oncogene and tumor suppressions have been established for c-Myc and promyelocytic leukemia (PML) protein, respectively. Myc is known to inhibit differentiation of hematopoietic precursor cells, and here we report that PML promotes cell differentiation. We further demonstrate that PML and Myc form a complex in vivo. The interaction of the two proteins leads to the destabilization of Myc in a manner dependent on the really interesting new gene (RING) domain of PML. Although several PML isoforms are able to interact with Myc, the ability to destabilize Myc is specific for PML4. Importantly, the PML-induced destabilization resulted in a reduction of promoter-bound Myc on Myc-repressed genes. Thereby, PML induced the re-activation of Myc-repressed target genes including the tumor suppressive genes of the cell cycle inhibitors cdkn1a/p21 and cdkn2b/p15. Together, these results establish PML-mediated destabilization of Myc and the derepression of cell cycle inhibitor genes as an important regulatory mechanism that allows cell differentiation and prevents aberrant proliferation driven by uncontrolled Myc activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- aa:
-
amino acids
- RARα:
-
retinoic acid receptor alpha
- HA:
-
hemagglutinin
- PML:
-
promyelocytic leukemia protein
- TGFβ:
-
transforming growth factor beta
References
Adhikary S, Eilers M . (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635–645.
Amati B . (2004). Myc degradation: dancing with ubiquitin ligases. Proc Natl Acad Sci USA 101: 8843–8844.
Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K et al. (1995). The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14: 1532–1541.
Buschbeck M, Hofbauer S, Croce LD, Keri G, Ullrich A . (2005). Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival. EMBO Rep 6: 63–69.
Cairo S, De Falco F, Pizzo M, Salomoni P, Pandolfi PP, Meroni G . (2005). PML interacts with Myc and Myc target gene expression is altered in PML-null fibroblasts. Oncogene 24: 2195–2203.
Di Croce L . (2005). Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet 14 (Spec No. 1): R77–R84.
Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. (2002). Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079–1082.
Eisenman RN . (2001). Deconstructing myc. Genes Dev 15: 2023–2030.
Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D et al. (1998). Cooperation between the RING+B1–B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16: 2905–2913.
Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B . (2001). Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069–2082.
Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ . (1997). Altered myeloid development and acute leukemia in transgenic mice expressing PML–RAR alpha under control of cathepsin G regulatory sequences. Blood 89: 376–387.
He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V et al. (1997). Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci USA 94: 5302–5307.
Herbst A, Salghetti SE, Kim SY, Tansey WP . (2004). Multiple cell-type-specific elements regulate Myc protein stability. Oncogene 23: 3863–3871.
Jensen K, Shiels C, Freemont PS . (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223–7233.
Kalejta RF, Shenk T . (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 100: 3263–3268.
Kanatani Y, Kasukabe T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Nagata N, Motoyoshi K et al. (1999). Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1. Cell Growth Differ 10: 705–712.
Lafarga M, Berciano MT, Pena E, Mayo I, Castano JG, Bohmann D et al. (2002). Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin and protein substrates of proteasome. Mol Biol Cell 13: 2771–2782.
Melnick A, Licht JD . (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
Nilsson JA, Cleveland JL . (2003). Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007–9021.
Rockel TD, Stuhlmann D, von Mikecz A . (2005). Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci 118: 5231–5242.
Salghetti SE, Kim SY, Tansey WP . (1999). Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18: 717–726.
Salomoni P, Pandolfi PP . (2002). The role of PML in tumor suppression. Cell 108: 165–170.
Seoane J, Le HV, Massague J . (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729–734.
Smith KP, Byron M, O'Connell BC, Tam R, Schorl C, Guney I et al. (2004). c-Myc localization within the nucleus: evidence for association with the PML nuclear body. J Cell Biochem 93: 1282–1296.
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H et al. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3: 392–399.
Strudwick S, Borden KL . (2002). Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities. Leukemia 16: 1906–1917.
Treier M, Staszewski LM, Bohmann D . (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787–798.
Villa R, Morey L, Raker VA, Buschbeck M, Gutierrez A, De Santis F et al. (2006). The methyl-CpG binding protein MBD1 is required for PML–RARalpha function. Proc Natl Acad Sci USA 103: 1400–1405.
Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V et al. (2003). Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351–360.
Acknowledgements
We thank KS Chang, Y Haupt, M Oren, B Amati, F Fuks, W Tansey, S Salghetti, M Edel, D Tenen, M Eilers, D Bowmann, S Jentsch and J Seoane for providing reagents. We gratefully acknowledge Hoffmann-LaRoche (Switzerland) for providing 1α,25-dihydroxyvitamin D3. We thank B Amati, PG Pelicci, T Graf, J Seoane and members of the Di Croce laboratory for helpful discussions. This work was supported by grants from ‘Fundació La Marató TV3’ and the Spanish Consolider (Ministerio de Educacion y Ciencia). MB was supported by Fellowships from the European Molecular Biology Organisation and Deutsche Forschungsgesellschaft; IU by an FPI fellowship and SM by the Deutsche Forschungsgemeinschaft and the German Israeli Foundation for Development and Scientific Research.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Buschbeck, M., Uribesalgo, I., Ledl, A. et al. PML4 induces differentiation by Myc destabilization. Oncogene 26, 3415–3422 (2007). https://doi.org/10.1038/sj.onc.1210128
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210128
Keywords
This article is cited by
-
MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD+ consumption
Nature Structural & Molecular Biology (2017)
-
E-box-independent regulation of transcription and differentiation by MYC
Nature Cell Biology (2011)
-
Regulation of apoptosis by PML and the PML-NBs
Oncogene (2008)
-
Selective activation of NFAT by promyelocytic leukemia protein
Oncogene (2008)
-
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Nature Reviews Molecular Cell Biology (2007)